These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 15778116

  • 1. The challenges of HIV vaccine development and testing.
    Burgers WA, Williamson C.
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
    [Abstract] [Full Text] [Related]

  • 2. An HIV vaccine: how and when?
    Esparza J.
    Bull World Health Organ; 2001 Apr; 79(12):1133-7. PubMed ID: 11799445
    [Abstract] [Full Text] [Related]

  • 3. [Vaccines against HIV].
    Holm-Hansen C.
    Tidsskr Nor Laegeforen; 2006 Nov 30; 126(23):3117-20. PubMed ID: 17160118
    [Abstract] [Full Text] [Related]

  • 4. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP, Osmanov SK, Kieny MP.
    Vaccine; 2006 May 08; 24(19):4062-81. PubMed ID: 16530298
    [Abstract] [Full Text] [Related]

  • 5. A fresh injection of interest for vaccines.
    AIDS Anal Afr; 1998 Feb 08; 8(1):3, 6. PubMed ID: 12293289
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Controversial HIV vaccine enters phase III trials amid skepticism.
    AIDS Alert; 1998 Dec 08; 13(12):133-4, 136. PubMed ID: 11366059
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Obstacles and progress toward development of a preventive HIV vaccine.
    Heyward WL, MacQueen KM, Jaffe HW.
    J Int Assoc Physicians AIDS Care; 1997 Aug 08; 3(8):28-34. PubMed ID: 11364630
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
    WHO/UNAIDS/IAVI International Expert Group.
    AIDS; 2007 Feb 19; 21(4):539-46. PubMed ID: 17301582
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.